(Q51555751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

7 November 2019

main subject

1 reference

1 reference

1 reference

1 reference

Robert Zygmunt Spaczynski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

B Kolodziejczyk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A J Duleba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Pawelczyk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1149-1154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Insulin as an effector of human ovarian and adrenal steroid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Adrenal involvement in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Can metformin reduce insulin resistance in polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Variation in facial and pubic hair growth in white women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Managing hirsutism in gynaecological practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding protei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900501-X

10.1016/S0015-0282(00)00501-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856473%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference